Konstantinos Mourouzis

10PUBLICATIONS
50CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Artificial life and complex adaptive systemsRespiratory diseasesFood properties (incl. characteristics and health benefits)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 29, 2026
Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

|Oct 29, 2025
Prognostic Impact of Obesity, Cardiometabolic Risk Factors, and Vascular Function Markers on Outcomes in Ischemic Cardiomyopathy.

Konstantinos Mourouzis, Vasiliki Tsigkou, Gerasimos Siasos

|Sep 23, 2025
Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial.

Luisa Freyer, Peter Spielbichler, Lukas von Stülpnagel

|Jul 24, 2025
Cardiac autonomic function score: a novel risk stratification tool in the cardiac intensive care unit based on periodic repolarization dynamics and deceleration capacity of heart rate (LMU-eICU study).

Mathias Klemm, Lukas von Stülpnagel, Valentin Ostermaier

|May 01, 2025
Endothelial Function and Pro-Inflammatory Cytokines as Prognostic Markers in Acute Coronary Syndromes.

Sotirios Tsalamandris, Leonidas Koliastasis, Antigoni Miliou

|Jan 08, 2025
Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i.

Emmanouil Korakas, John Thymis, Evangelos Oikonomou

Pageof 2

Frequent Collaborators

4 joint publications

Konstantinos D Rizas

4 joint publications

Evangelos Oikonomou

3 joint publications

Steffen Massberg

3 joint publications

Lukas von Stülpnagel